Additionally, LEP stimulates breast cancer cell proliferation and migration via MAPK pathway activation [19], and modulates the PI3K/AKT pathway to facilitate epithelial–mesenchymal transition (EMT), migration, and angiogenesis [20]. Here, AKT1 is linked to breast carcinoma.